Skip to main content
Ying Taur, MD, Infectious Disease, New York, NY

YingTaurMDMPH

Infectious Disease New York, NY

Transplant/Immunocompromised States

Assistant Attending, Medicine, Weill Cornell Medical College

Dr. Taur is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Taur's full profile

Already have an account?

  • Office

    530 East 74th Street
    New York, NY 10021

Summary

  • Dr. Ying Taur is an infectious disease specialist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from New York Medical College and has been in practice 14 years. He specializes in transplant/immunocompromised states.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Infectious Disease, 2006 - 2009
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2003 - 2006
  • New York Medical College
    New York Medical CollegeClass of 2003

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - 2026
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Journal Articles

  • Gut Microbiota Dysbiosis and Diarrhea in Kidney Transplant Recipients  
    Eric Pamer, Manikkam Suthanthiran, Ying Taur, Michael J Satlin, Darshana Dadhania, John Richard Lee, Carl Crawford, Michelle Lubetzky, American journal of transplantation

Abstracts/Posters

  • Sparing of the Lower Gastrointestinal Tract Microbiota Is Associated with Reduced Acute Graft-Versus-Host Disease
    Ying Taur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Antibiotic Exposures and Dietary Intakes Are Associated with Changes in Microbiota Compositions in Allogeneic Hematopoietic Stem Cell Transplant Patients
    Ying Taur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation
    Ying Taur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Press Mentions

  • Cancer Immunotherapy Tied to Severe COVID-19 Outcomes
    Cancer Immunotherapy Tied to Severe COVID-19 OutcomesJune 25th, 2020
  • Should You Delay Cancer Treatment Because of COVID-19? Study Says Most Treatments Don’t Worsen Coronavirus Infection
    Should You Delay Cancer Treatment Because of COVID-19? Study Says Most Treatments Don’t Worsen Coronavirus InfectionJune 24th, 2020